Autoimmune Diseases  >>  insulin peglispro (LY2605541)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
insulin peglispro (LY2605541) / Eli Lilly
NCT01481779 / 2011-001261-40: A Study in Participants With Type 1 Diabetes Mellitus

Completed
3
455
Japan, US, Europe, RoW
Glargine, LY2605541, Insulin Lispro, LY275585, Humalog
Eli Lilly and Company
Diabetes Mellitus, Type 1
05/13
06/14
IMAGINE 3, NCT01454284 / 2011-001253-82: A Study in Participants With Type I Diabetes Mellitus

Completed
3
1114
US, Canada, Europe, RoW
Glargine, LY2605541, Insulin Lispro, LY275585, Humalog
Eli Lilly and Company
Diabetes Mellitus, Type 1
02/14
02/14
IMAGINE 7, NCT01792284: A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus

Completed
3
212
US
LY2605541, Insulin Peglispro, Insulin Lispro
Eli Lilly and Company
Type 1 Diabetes Mellitus
04/14
04/14

Download Options